Figure 2From: Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor Dose-dependent growth inhibition of parental line (C2) and three resistant sublines (TR1, TR2, TR3) after incubation with increasing concentrations of vinblastine or CCNU (lomustine) for 72 hours. Back to article page